BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2
1 clinical trials · Condition
◉ Watch BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2
| Record | Firm | Date |
|---|---|---|
| Carboplatin or Olaparib for BRcA Deficient Prostate Cancer (NCT04038502) | VA Office of Research and Development | 2019-10-01 |
Track BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 automatically
Every clearance here is in the API, with alerts when new ones post.